While AI offers remarkable efficiency, the pharmaceutical industry must address concerns about “black box” predictions – AI ...
RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.
ZME Science on MSN13d
Finally, mRNA vaccines against cancer are starting to become a realityRNA vaccines were first developed years ago to target cancers and now they're really starting to show promise.
HONG KONG, March 24, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 23, 2025, the company's independently developed mRNA ...
TechInvention and Belgium-based Quantoom Biosciences have entered a partnership to enhance the local manufacturing of mRNA ...
Dr Sanjay Singh, CEO of Gennova Biopharmaceuticals, said the firm will do preclinical and phase 1 vaccine tests in India, ...
Pune: Emcure Pharmaceuticals Ltd. subsidiary Gennova Biopharmaceuticals Ltd., is advancing the development of a pathbreaking ...
EVM14 received FDA clearance for clinical trials, marking Everest Medicines’ first in-house developed therapeutic to reach ...
Nipah virus, a highly lethal pathogen belonging to the Paramyxovirus family, has caused multiple outbreaks in South and ...
HONG KONG, March 24, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 23, 2025, the company's independently developed mRNA ...
In just one month, AIM has leveraged its independently innovated mRNA technology platform to deliver two major products, both of which have received recognition from international authoritative ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback